Altimmune Inc. (ALT)

Trade ALT now with
1/23/2020 7:13:48 AM Altimmune Announces Positive Results For ALT-702 In Preclinical Model Of Colorectal Cancer
9/9/2019 7:09:54 AM Altimmune Appoints Scott Harris As Chief Medical Officer
7/15/2019 7:07:58 AM Altimmune Announces Closing Of Acquisition Of Spitfire Pharma
7/9/2019 7:19:11 AM Altimmune To Acquire Spitfire Pharma
7/9/2019 7:05:14 AM Altimmune Agrees To Acquire Spitfire Pharma; Transaction To Close During July
6/10/2019 8:10:13 AM Altimmune Reports Pre-IND Meeting For HepTcell; Phase 2 Trial To Start In 2020
6/5/2019 8:12:57 AM Altimmune Receives Addl Patent Protection For Its HepTcell And ALT-702 Programs
3/19/2019 7:09:04 AM Altimmune Announces Positive Results From NasoVAX Extension Study
1/29/2019 8:08:42 AM Altimmune Announces Presentation Of HepTcell Phase 1 Results At International Liver Congress™ In Vienna, Austria
12/13/2018 7:04:03 AM Altimmune Announces Clinical Program Updates And Plans For Pipeline Expansion
11/27/2018 9:04:00 AM Altimmune Appoints Vipin Garg As Its President And CEO Succeeding Bill Enright
10/8/2018 9:05:02 AM Altimmune Plans $25 Mln Registered Direct Offering
9/24/2018 9:10:40 AM Altimmune Announces $4.9 Mln Registered Direct Offering Of Common Stock